Imcyse raised €35M in a Series B round in Apr 2019. The company is based in Liege, Belgium. Investors in the round: LSP BioVentures. Data as of 7 Aug 2026.
Reported in EUR — no conversion. €35M
Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.
This is the company's only recorded round.
